Effects of Three Different Methods Applied to Patients After Spine Surgery on Nausea, Thirst and Comfort

May 8, 2026 updated by: Özge İşeri, Ondokuz Mayıs University
The aim of this study was to determine the effects of postoperative methods on nausea, thirst and comfort levels of patients undergoing spinal surgery.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Within the scope of this randomized controlled study, it is aimed to evaluate the effectiveness of ice, mouthwash and menthol lozenge interventions to provide effects on postoperative nausea, thirst and comfort in patients undergoing spinal surgery

Study Type

Interventional

Enrollment (Estimated)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey (Türkiye)
      • Amasya, Turkey (Türkiye)
        • Recruiting
        • Amasya Şerefeddin Sabuncuoğlu Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients who underwent lumbar disc herniation (LDH) surgery
  • LDH surgery patients who recieve general anesthesia
  • The patients who were conscious
  • The duration of surgery is between 0-3 hours

Exclusion Criteria:

  • Patients who cannot understand and speak Turkish
  • Allergic patients to menthol
  • Patients who received spinal anesthesia
  • Patients with lesions on the oral mucosa and lips
  • Patients requiring intensive care after surgical intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Routine care
Experimental: Ice cube
Other: Ice cube
ıce cube
Experimental: Mouth wash
Other: Mouth wash
Mouth wash
Experimental: Menthol lozenge
Other: Menthol lozenge
menthol lozenge

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nausea
Time Frame: once before the application and 60, 120, 180 and 240 min. after arrival at the clinic
Nausea level: It consists of a numeric scale. Among the numbers, ''0'' corresponds to ''no thirst/nausea'' and ''10'' corresponds to ''very much thirst/nausea''. As the number increases, nausea and thirst will be accepted as increased. There is no cut-off point.
once before the application and 60, 120, 180 and 240 min. after arrival at the clinic
Thirst
Time Frame: once before the application and 60, 120, 180 and 240 min. after arrival at the clinic
Thirst level: A minimum score of 12 and a maximum score of 60 can be obtained from the scale. The higher the score obtained from the scale, the higher the level of thirst discomfort of the patients.
once before the application and 60, 120, 180 and 240 min. after arrival at the clinic
Comfort
Time Frame: once before the application and 240 min. after arrival at the clinic
Comfort level: The highest score that can be obtained from the scale is 192 and the lowest score is 48. A high SCS scoring indicates a high comfort level of the individual.
once before the application and 240 min. after arrival at the clinic

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ondokuz Mayıs University

Investigators

  • Principal Investigator: Özge İşeri, PhD, Ondokuz Mayıs University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2025

Primary Completion (Actual)

December 30, 2025

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

February 22, 2025

First Submitted That Met QC Criteria

February 27, 2025

First Posted (Actual)

March 4, 2025

Study Record Updates

Last Update Posted (Actual)

May 13, 2026

Last Update Submitted That Met QC Criteria

May 8, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • A.30.2.ODM.0.20.08/569-677

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Since this is a doctoral study, the results can be shared at the end of the thesis

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Surgery

Clinical Trials on Ice cube

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe